Hot Line Trials of the European Society of Cardiology 2024 Congress

 

Here's TCTMD's handy guide to the 12 Hot Line trial sessions at the European Society of Cardiology's 2024 Congress. All Hot Line presentations will take place in room "London." The TCTMD news and multimedia teams will be on the ground at the ExCel center.  For a glimpse of what to expect, check out our Editor's Corner curtain-raiser: What’s Going to Be Hot at ESC 2024 and Rox Heart Radio: What's Ahead at ESC 2024.

 

Hot Line 1: Friday 30th August, 11:00 – 12:09

11:00: HELIOS-B - Primary results from phase 3 study of vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy 

  • Presenter TBC

11:22: ABYSS - Beta blocker interruption in post-myocardial infarction patients

  • Johanne Silvain (Sorbonne University - Paris, France)

11:47: STOP-or-NOT - Impact of renin-angiotensin system inhibitors continuation versus discontinuation on postoperative complications: a multicenter randomised, controlled trial 

  • Matthieu Legrand (University of California at San Francisco - San Francisco, United States of America)

 

Hot Line 2: Saturday 31st August, 08:15 – 09:46

8:15: The BedMed and BedMed-Frail randomised controlled trials - Effect of antihypertensive timing on mortality and morbidity 

  • Scott Garrison (University of Alberta - Edmonton, Canada)

8:30: Meta-analysis of trials of antihypertensive medication bedtime dosing including individual-patient data from BedMed and BedMed-Frail 

  • Ricky Turgeon (University of British Columbia - Vancouver, Canada)

8:54: GMRx2 - Efficacy and safety of a novel triple single pill combination

  • Anthony Rodgers (The George Institute for Global Health - Sydney, Australia)

9:09: QUADRO - A single 4-drug combination in hypertension 

  • Stefano Taddei (University of Pisa - Pisa, Italy)

9:21: VERONICA - Nigeria - deliVERy of Optimal blood pressure coNtrol in afrICA

  • Dike Bevis Ojji (University of Abuja - Abuja, Nigeria)

 

Hot Line 3: Saturday 31st August, 11:00 – 12:06

11:00: Tri.fr trial - Multicentric randomised evaluation of the transcatheter edge-to-edge repair in the treatment of severe isolated secondary tricuspid regurgitation

  • Erwan Donal (Hospital Pontchaillou of Rennes - Rennes, France)

11:22: MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

  • Volker Rudolph (Heart and Diabetes Center NRW - Bad Oeynhausen, Germany)

11:44: RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure 

  • Stefan Anker (Charite University Hospital - Berlin, Germany)

 

Hot Line 4: Saturday 31st August, 16:15 – 17:21

16:15: ASSURE DES - Perioperative antiplatelet therapy in patients with coronary stents before non-cardiac surgery 

  • Jung-Min Ahn (Asan Medical Center - Seoul, Korea (Republic of))

16:37: SWEDEGRAFT - No-touch vein grafts in coronary artery bypass grafting 

  • Stefan James (Uppsala University - Uppsala, Sweden)

16:29: The TIGHT-K trial - Potassium supplementation and the prevention of atrial fibrillation after cardiac surgery 

  • Benjamin O'Brien (Deutsches Herzzentrum der Charité - Berlin, Germany)

 

Hot Line 5: Saturday 31st August, 17:35 – 18:41

17:35: POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI? 

  • Dirk Jan van Ginkel (St Antonius Hospital - Nieuwegein, Netherlands (The))

17:57: NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 

  • Jacob Thomsen Loenborg (Copenhagen University Hospital - Copenhagen, Denmark)

18:19: RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis 

  • Helene Eltchaninoff (University Hospital of Rouen - Rouen, France)

 

Hot Line 6: Sunday 1st September, 08:15 – 09:41

8:15: STEEER-AF - Stroke prevention and rhythm control therapy 

  • Dipak Kotecha (University of Birmingham - Birmingham, United Kingdom of Great Britain & Northern Ireland)

8:40: OCEANIC-AF - Asundexian versus apixaban in patients with atrial fibrillation 

  • Manesh Patel (Duke University Medical Center - Durham, United States of America)

9:16: EPIC-CAD - Edoxaban monotherapy vs. dual antithrombotic therapy for atrial fibrillation and stable coronary arthery disease 

  • Gi-Byoung Nam (Asan Medical Center - Seoul, Korea (Republic of))

 

Hot Line 7: Sunday 1st September, 11:00 – 12:06

11:00: FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction 

  • Scott Solomon (Brigham and Women's Hospital, Harvard Medical School - Boston, United States of America)

11:22: MRAs in HF - An individual patient data meta-analysis of randomised trials 

  • Pardeep Jhund (University of Glasgow - Glasgow, United Kingdom of Great Britain & Northern Ireland)

11:44: FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials 

  • Muthiah Vaduganathan (Brigham and Women's Hospital, Harvard Medical School - Boston, United States of America)

 

Hot Line 8: Sunday 1st September, 16:15 – 17:21

16:15: SCOFF - Fasting or no fasting before cardiac catherisation procedures 

  • David Ferreira (John Hunter Hospital - Newcastle, Australia)

16:37: EARTH-STEMI - Complete vs. culprit-only revascularization in older STEMI patients 

  • Gianluca Campo (University Hospital of Ferrara - Ferrara, Italy)

16:59: SENIOR RITA - Older patients with non-ST segment elevation myocardial infarction randomised interventional treatment trial 

  • Vijay Kunadian (Newcastle University - Newcastle-Upon-Tyne, United Kingdom of Great Britain & Northern Ireland)

 

Hot Line 9: Sunday 1st September, 17:35 – 18:36

17:35: GUARD-AF - ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals

  • Renato Lopes (Duke University Medical Center - Durham, United States of America)

17:50: STROKESTOP II - Randomised systematic NT-proBNP and ECG screening for atrial fibrillation among 75 year-olds 

  • Katrin Kemp Gudmundsdottir (Karolinska Institutet Danderyd Hospital - Stockholm, Sweden)

18:14: MIRACLE-AF - A Novel Model of IntegRAted Care of OLdEr Patients with Atrial Fibrillation in rural China 

  • Minglong Chen (The First Affiliated Hospital of Nanjing Medical University - Nanjing, China)

 

Hot Line 10: Monday 2nd September, 11:00 – 12:06

11:00: SHAM-PVI - A randomised sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation 

  • Rajdip Dulai (University College London - London, United Kingdom of Great Britain & Northern Ireland)

11:22: SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation 

  • Masaharu Masuda (Kansai Rosai Hospital - Amagasaki, Japan)

11:44: CRABL-HF - Cryoballoon vs. Radiofrequency Ablation of AF in Patients with Heart Failure 

  • Kengo Kusano (National Cerebral and Cardiovascular Center Hospital - Osaka, Japan)

 

Hot Line 11: Monday 2nd September, 13:45 – 14:45

13:45: OCCUPI - Optical coherence tomography-guided coronary intervention in patients with complex lesions 

  • Kim Byeong-Keuk (Severance Cardiovascular Hospital, Yonsei University College of Medicine - Seoul, Korea (Republic of))

14:05: INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

  • David Erlinge (Lund University - Lund, Sweden)

14:25: REC-CAGEFREE I - A noninferiority study of drug-coated balloon vs drug-eluting stent for de novo coronary artery lesions 

  • Ling Tao (Xijing Hospital of the Fourth Military Medical University - Xi'an, China)

 

Hot Line 12: Monday 2nd September, 15:15 – 16:21

15:15: PROTEUS - A prospective randomised controlled trial evaluating the use of artificial intelligence in stress echocardiography

  • Ross Upton (University of Oxford - Oxford, United Kingdom of Great Britain & Northern Ireland)

15:37: RAPIDxAI - Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting evidence to practice using artificial intelligence 

  • Derek Chew (Victorian Heart Hospital - Melbourne, Australia)

15:59: WESTCOR-POC - Point of care versus centralised high-sensitivity cardiac troponin in the emergency department 

  • Viola Thulin (Haukeland University Hospital - Bergen, Norway)